ArticleDie Naturwissenschaften2026
Chronic oral toxicity of lithium citrate in honeybees (Apis mellifera L.): impacts on survival, midgut histopathology and gut microbiota.
Article in Die Naturwissenschaften, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The search for effective alternatives to conventional acaricides has positioned lithium as a promising experimental candidate for controlling Varroa destructor; however, its physiological impact on the honeybee (Apis mellifera) remains insufficiently characterized. This study evaluated the chronic oral toxicity of lithium citrate over a 10-day exposure period, focusing on survival, midgut histopathological changes, and gut microbiota dynamics. Newly emerged bees were exposed to sugar syrup containing 12.5, 25, and 50 mM lithium citrate. Mortality increased monotonically with dose: 10-day survival was 0.94 in the control and 0.84, 0.22, and 0 at 12.5, 25, and 50 mM, respectively (all pairwise contrasts significant, Benjamini-Hochberg correction). Histological analysis of the midgut revealed pronounced epithelial damage, characterized by severe desquamation and cellular shedding into the lumen, even at the lower dose of 12.5 mM, with the highest severity at 12.5 mM rather than 25 mM; the peritrophic membrane remained intact in all groups. Furthermore, 16S rRNA gene sequencing revealed variation in the relative abundance of several core gut bacteria across treatment groups, although neither alpha- nor beta-diversity differed significantly among groups. At the highest lithium concentration (25 mM), Gilliamella showed a markedly lower median relative abundance, whereas Frischella was relatively more abundant; however, these patterns were not statistically supported by differential abundance analysis and did not indicate a consistent concentration-dependent response. Given the limited number of biological replicates (n = 3 per group), these compositional patterns should be regarded as preliminary. These findings suggest that lithium citrate, despite its varroacidal potential, acts as a significant physiological stressor, compromising the structural integrity of the digestive tract and disrupting microbial homeostasis. Consequently, the development of lithium-based treatments must carefully consider both lethal and sublethal effects at the individual level, and colony-level consequences remain to be evaluated.
Indexed as
Identifiers
42873245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.